For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Blog
Supreme Court Hears Oral Arguments over Vaccine Mandates
Today the Supreme Court heard over three hours of oral arguments on two of the Biden administration’s COVID-19 vaccine mandates. In the…
New York Post
The Science Shows Eric Adams is Right in Fight to Keep NYC Schools Open
As new cases of the Omicron variant surge, thousands of schools have delayed a return to in-person learning. Cities including Atlanta, Milwaukee, Cleveland and…
City Journal
Omicron’s Silver Lining
New Covid-19 infections are reaching record levels in the U.S. and Europe. The surge is due both to the…
New York Post
New York’s Racial ‘Risk Factor’ for COVID Treatment is Illegal and Immoral
New York City’s and state’s departments of health have reached a divisive and destructive low. In new guidelines rationing scarce, lifesaving oral antiviral medications and…
National Review
Confronting Omicron: One Step Forward, One Step Static
President Joe Biden’s recent address on the Omicron variant was full of holiday miracles. After nearly a year in office, Biden finally conceded…
The Wall Street Journal
Drug Prices Haven’t Been Going Up
Build Back Better may be dead, but its proposed drug price controls will likely reappear: negotiating prices for high-cost drugs in Medicare and price…